Live Breaking News & Updates on Tianqing

Stay updated with breaking news from Tianqing. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Sino Biopharmaceutical Limited (OTCMKTS:SBMFF) Sees Large Increase in Short Interest

Sino Biopharmaceutical Limited (OTCMKTS:SBMFF) Sees Large Increase in Short Interest
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Sino Biopharmaceutical Limited , Sino Biopharmaceutical , Get Free Report , Biopharmaceutical Limited , Modernised Chinese Medicines , Chemical Medicines , Sino Biopharmaceutical Daily ,

Sino Biopharmaceutical (OTCMKTS:SBMFF) Shares Down 12.7%

Sino Biopharmaceutical (OTCMKTS:SBMFF) Shares Down 12.7%
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Sino Biopharmaceutical Limited , Sino Biopharmaceutical , Sino Biopharmaceutical Company Profile , Get Free Report , Biopharmaceutical Limited , Modernised Chinese Medicines , Chemical Medicines , Sino Biopharmaceutical Daily ,

Akeso Marks Profit Milestone With Swift Rights Issue - Summit Therapeutics (NASDAQ:SMMT)

Key Takeaways: Akeso swung to an annual profit of 1.94 billion yuan, boosted by licensing income of 2.92 billion yuan The next highly anticipated product in the firm’s drug pipeline is ivonescimab, the first PD-1/VEGF bispecific antibody to enter Phase III clinical trials By Molly Wen ....

Hong Kong , United States , Molly Wen , Akeso Inc , Chia Tai Tianqing Pharmaceutical Group , Henlius Biotech ,